1800 202 8726
Reading your cytology report

What Is — 'Scant Cellularity'?

You paid for a biopsy and waited for the result, and the report came back with a phrase instead of an answer. 'Scant cellularity' is not a diagnosis — it is the laboratory telling you there were not enough cells in the sample to make one.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • A statement about the sample — Scant cellularity describes what the laboratory received, not what the lesion is.
  • Not a positive or negative result — It means the question is still open — neither cancer confirmed nor ruled out.
  • A recognised outcome, not an error — Major pathology bodies have formal categories for insufficient samples so they are reported honestly rather than guessed at.
  • A path still exists — Most inconclusive biopsies can be followed by a repeat that gives a result.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

'Scant cellularity' means the biopsy sample contained too few cells for the laboratory to give a definitive result. It is a technical finding about the sample, not a finding about the cancer itself. Your oncologist will tell you whether a repeat procedure is needed and what type would work best for your situation.

What do the phrases on a cytology report mean?

Report phraseWhat it meansWhat usually happens next
Adequate / satisfactoryEnough cells were collected for analysisThe laboratory proceeds to give a diagnosis
Scant cellularityToo few cells to give a reliable resultYour doctor discusses whether a repeat is needed
AcellularNo cells found in the sample at allA repeat procedure is almost always discussed
Unsatisfactory / non-diagnosticA technical problem prevented analysisA repeat is usually recommended

What to do now

  • Bring this report and your recent imaging to your next appointment.
  • Note which site was biopsied and what technique was used.
  • Ask your doctor: 'Is a repeat biopsy recommended, and if so, what type?'
  • Ask whether imaging guidance would improve accuracy for a second attempt.
  • Do not start, stop, or change any treatment on the basis of this result alone.
  • If a second opinion is planned, bring this report with you.

Why does scant cellularity happen?

A biopsy needle samples a tiny area. If the tumour has a lot of dead tissue at its centre, if the lesion is very small, or if the site is difficult to reach, the sample may not contain enough cells to read — even when the needle was placed in exactly the right location.

It can also happen when cells that were collected did not survive slide preparation, or when the sample was spread too thinly. These are technical factors, not a measure of how carefully the procedure was done.

Scant cellularity is a recognised category in pathology. It happens often enough that major pathology bodies have set formal adequacy standards, precisely so that borderline results are reported honestly rather than overread.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What are your options now?

A single inconclusive result does not leave you without a path forward. Your oncologist will review this result alongside your imaging and clinical picture to decide whether more tissue is needed and, if so, how best to get it.

For some sites, a repeat fine needle aspiration with real-time ultrasound guidance produces a better yield. For others, a core needle biopsy — which takes a larger sliver of tissue — gives the laboratory more to work with. In some cases, a surgical biopsy is the most reliable option.

This is a decision your oncologist makes with you, based on where the lesion is, what has already been tried, and what is most safely achievable. No single path is right for every patient.

Did you know?

The phrase 'scant cellularity' comes from agreed international reporting standards. These categories exist because major pathology bodies decided it is safer to honestly report an insufficient sample than to risk a wrong diagnosis on too little evidence.

Source: College of American Pathologists; International Academy of Cytology

Questions about repeating the biopsy

Does scant cellularity mean the cancer is hard to find?

Not necessarily. It means the sample that reached the laboratory had too few cells — not that the lesion cannot be sampled at all. Dense tumours, highly necrotic lesions, and certain anatomical locations do produce lower yields, but in many cases a repeat with different guidance or a different technique gives a clear result. Your oncologist can tell you whether anything specific about your lesion makes it technically more challenging to sample.

How soon do I need to repeat it?

There is no single answer that applies to every patient. The urgency depends on what the imaging showed, how the lesion appears to be changing, and what other clinical information your team already has. Your oncologist will advise whether the repeat needs to happen within days, within weeks, or whether a short period of watchful waiting is safe while you plan the next step.

Will a repeat biopsy be riskier or more painful?

The risks of a repeat are generally similar to the first procedure. Your team will have learned from the first attempt — which site was used and what technique was applied. Some repeats use better imaging guidance than the first attempt, which can improve both accuracy and safety. Your oncologist will explain the specific risks for whichever technique is being considered for your case.

What type of biopsy is most likely to give a result this time?

This depends on the location and nature of the lesion. A fine needle aspiration is quick and minimally invasive but yields fewer cells. A core needle biopsy takes a larger tissue sample and is more often adequate, but involves a slightly larger needle and a slightly higher procedural risk. For deeply placed lesions, ultrasound or CT guidance significantly improves accuracy. Your treating doctor is the right person to recommend the approach, as they can weigh the specifics of your case.

How much will a repeat biopsy cost?

Cost varies considerably by technique, whether imaging guidance is needed, and whether it is done as a day procedure or requires a short stay. These figures change over time and between centres — ask for a written estimate before the procedure rather than relying on any figure you find online. Your CION team can discuss what the repeat is likely to involve and help you understand the costs before you commit.

Can I skip the repeat and go straight to surgery?

That depends on what the imaging shows and what surgery is being considered. Some procedures are designed to be both diagnostic and therapeutic — they remove the lesion and send it for analysis at the same time. Others need a confirmed tissue diagnosis before the surgeon will proceed, because the operation planned depends on what the cancer type turns out to be. Your oncologist and surgeon need to discuss this together, and it is a reasonable question to put to them directly.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does 'scant cellularity' mean I do not have cancer?

No. Scant cellularity is a statement about the sample, not about the lesion. The laboratory is saying there were not enough cells to make a diagnosis either way — cancer has not been confirmed, but it has not been ruled out either. Your imaging and clinical picture still stand. What this result tells you is that a tissue diagnosis has not yet been reached from this particular sample.

Can my oncologist diagnose me from the rest of the report?

Sometimes. If your imaging strongly suggests a particular diagnosis, and your oncologist has supporting information — blood markers, symptom history, clinical examination — they may be able to reach a working diagnosis without waiting for tissue. More often, they will want a confirmed tissue result before recommending treatment, because treatment decisions for cancer are ideally made on confirmed pathology.

Is it the fault of the laboratory or the doctor who performed the biopsy?

Neither. Scant cellularity reflects the biology of the lesion being sampled as much as it reflects technique. Some lesions yield fewer cells regardless of how accurately the needle was placed. Major pathology guidelines explicitly recognise this, which is why inconclusive results have formal reporting categories rather than being classified as errors. Framing it as fault is not how your oncology team sees it.

What if I cannot afford a repeat biopsy?

Tell your oncologist. Cost is a real constraint, and your team can discuss which type of repeat gives the most information for the least expense, whether imaging you have already had can guide the approach, and what the consequences of a delay are for your specific situation. A frank conversation about what is financially feasible is part of planning care, not an exceptional request.

How many times can a biopsy come back inconclusive?

There is no fixed number, but it is unusual to repeat the same technique more than once without changing the approach. After two inconclusive results from the same site, most oncologists would consider whether a different technique — core biopsy, surgical biopsy, or a different sampling site — would be more productive. Your team will weigh the risks of each option against the need for a tissue diagnosis.

Is scant cellularity the same as a negative biopsy?

No, they mean different things. A negative biopsy has enough cells to examine and the pathologist found no cancer in them. Scant cellularity means there were not enough cells to examine — the result is inconclusive, not negative. This distinction matters: a negative result in the right context can be reassuring, whereas an inconclusive result means the question has not yet been answered.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation